The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cui, X.
Right arrow Articles by Levine, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cui, X.
Right arrow Articles by Levine, S. J.
The Journal of Immunology, 2003, 171: 6814-6819.
Copyright © 2003 by The American Association of Immunologists

Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding

Xinle Cui, Farshid N. Rouhani, Feras Hawari and Stewart J. Levine1

Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892

Proteolytic cleavage of the extracellular domain of the type II IL-1 decoy receptor (IL-1RII) generates soluble IL-1-binding proteins that prevent excessive bioactivity by binding free IL-1. In this study we report that an aminopeptidase, aminopeptidase regulator of TNFR1 shedding (ARTS-1), is required for IL-1RII shedding. Coimmunoprecipitation experiments demonstrate an association between endogenous membrane-associated ARTS-1 and a 47-kDa IL-1RII, consistent with ectodomain cleavage of the membrane-bound receptor. A direct correlation exists between ARTS-1 protein expression and IL-1RII shedding, as cell lines overexpressing ARTS-1 have increased IL-1RII shedding and decreased membrane-associated IL-1RII. Basal IL-1RII shedding is absent from ARTS-1 knockout cell lines, demonstrating that ARTS-1 is required for constitutive IL-1RII shedding. Similarly, PMA-mediated IL-1RII shedding is almost entirely ARTS-1-dependent. ARTS-1 expression also enhances ionomycin-induced IL-1RII shedding. ARTS-1 did not alter levels of membrane-associated IL-1RI or IL-1R antagonist release from ARTS-1 cell lines, which suggests that the ability of ARTS-1 to promote shedding of IL-1R family members may be specific for IL-1RII. Further, increased IL-1RII shedding by ARTS-1-overexpressing cells attenuates the biological activity of IL-1{beta}. We conclude that the ability of ARTS-1 to enhance IL-1RII shedding represents a new mechanism by which IL-1-induced cellular events can be modulated. As ARTS-1 also promotes the shedding of the structurally unrelated 55-kDa, type I TNF receptor and the IL-6R, we propose that ARTS-1 may play an important role in regulating innate immune and inflammatory responses by increasing cytokine receptor shedding.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
D. Harvey, J. J. Pointon, D. M. Evans, T. Karaderi, C. Farrar, L. H. Appleton, R. D. Sturrock, M. A. Stone, U. Oppermann, M. A. Brown, et al.
Investigating the genetic association between ERAP1 and ankylosing spondylitis
Hum. Mol. Genet., November 1, 2009; 18(21): 4204 - 4212.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Bellehumeur, J. Blanchet, J.-Y. Fontaine, N. Bourcier, and A. Akoum
Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms
Hum. Reprod., September 1, 2009; 24(9): 2193 - 2204.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
R. A. COLBERT, A. A. DEODHAR, D. FOX, E. M. GRAVALLESE, M. A. KHAN, D. McGONAGLE, J. D. REVEILLE, G. SCHETT, M. WEISMAN, D. O. CLEGG, et al.
Entheses and Bones in Spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)
J Rheumatol, July 1, 2009; 36(7): 1527 - 1531.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. A. Brown
Breakthroughs in genetic studies of ankylosing spondylitis
Rheumatology, February 1, 2008; 47(2): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Akoum, C. Lawson, C. Herrmann-Lavoie, and R. Maheux
Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis
Hum. Reprod., May 1, 2007; 22(5): 1464 - 1473.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-H. Kuhn, E. Marjaux, A. Imhof, B. De Strooper, C. Haass, and S. F. Lichtenthaler
Regulated Intramembrane Proteolysis of the Interleukin-1 Receptor II by {alpha}-, beta-, and {gamma}-Secretase
J. Biol. Chem., April 20, 2007; 282(16): 11982 - 11995.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Sather, K. D. Kenyon, J. B. Lefkowitz, X. Liang, B. C. Varnum, P. M. Henson, and D. K. Graham
A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation
Blood, February 1, 2007; 109(3): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Yan, V. V. Parekh, Y. Mendez-Fernandez, D. Olivares-Villagomez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules
J. Exp. Med., March 20, 2006; 203(3): 647 - 659.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis
Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. White, J. E. Brestelli, K. H. Kaestner, and L. E. Greenbaum
Identification of Transcriptional Networks during Liver Regeneration
J. Biol. Chem., February 4, 2005; 280(5): 3715 - 3722.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.